CSMED Stock Overview
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
CS Medica A/S Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | DKK 12.85 |
52 Week High | DKK 17.99 |
52 Week Low | DKK 3.05 |
Beta | -1.64 |
11 Month Change | 126.30% |
3 Month Change | 107.66% |
1 Year Change | 76.80% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 20.61% |
Recent News & Updates
Shareholder Returns
CSMED | SE Pharmaceuticals | SE Market | |
---|---|---|---|
7D | -22.5% | -2.4% | -4.3% |
1Y | 76.8% | 74.8% | 12.6% |
Return vs Industry: CSMED exceeded the Swedish Pharmaceuticals industry which returned 74.8% over the past year.
Return vs Market: CSMED exceeded the Swedish Market which returned 12.6% over the past year.
Price Volatility
CSMED volatility | |
---|---|
CSMED Average Weekly Movement | 26.7% |
Pharmaceuticals Industry Average Movement | 10.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in SE Market | 12.2% |
10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: CSMED's share price has been volatile over the past 3 months.
Volatility Over Time: CSMED's weekly volatility (27%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 9 | Lone Henriksen | www.cs-medica.com |
CS MEDICA A/S develops, manufactures, and commercializes over the counter medical products containing cannabinoids for the treatment of psoriasis and arthritis. It offers gels for psoriasis, arthritis, protective nasal, and wound healing; and CBD anti-hair loss serum, as well as sleep nasal sprays and pain patches. The company primarily offers its products under the CANNASEN brand name.
CS Medica A/S Fundamentals Summary
CSMED fundamental statistics | |
---|---|
Market cap | DKK 102.28m |
Earnings (TTM) | -DKK 13.12m |
Revenue (TTM) | DKK 4.88m |
32.4x
P/S Ratio-12.1x
P/E RatioIs CSMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CSMED income statement (TTM) | |
---|---|
Revenue | DKK 4.88m |
Cost of Revenue | DKK 2.71m |
Gross Profit | DKK 2.18m |
Other Expenses | DKK 15.29m |
Earnings | -DKK 13.12m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 16, 2024
Earnings per share (EPS) | -1.06 |
Gross Margin | 44.60% |
Net Profit Margin | -268.51% |
Debt/Equity Ratio | 228.9% |
How did CSMED perform over the long term?
See historical performance and comparison